Trial intelligence / Profile preview

Haimpoffin photodynamic therapy for port-wine stain: treatment number and efficacy plateau

ChiCTR2100052549Phase 4Recruiting

Sponsor
Xi'an Jiaotong University
Start
Aug 2020
Modality
Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of hemoporfin in port-wine stain (2 arms), sponsored by Xi'an Jiaotong University. Primary endpoints: Number of treatment sessions and Effectiveness rate. Started Aug 2020; status: recruiting.

02

Drugs

hemoporfin
03

Conditions

port-wine stain

Beyond the preview

Go deeper on ChiCTR2100052549.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100052549.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call